Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise. - Test2 - elhamkhani - TriplyDB

Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise.

Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise.

http://www.wikidata.org/entity/Q35254797

about

Fertility preservation during cancer treatment: clinical guidelines How do chemotherapeutic agents damage the ovary?Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans Stem cells' guided gene therapy of cancer: New frontier in personalized and targeted therapy.TOP2β is essential for ovarian follicles that are hypersensitive to chemotherapeutic drugs Current state and controversies in fertility preservation in women with breast cancer.Estimates of young breast cancer survivors at risk for infertility in the U.S.Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.The effects of DNA double-strand breaks on mouse oocyte meiotic maturation.Enhanced susceptibility of ovaries from obese mice to 7,12-dimethylbenz[a]anthracene-induced DNA damage Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin Eradication of Human Ovarian Cancer Cells by Transgenic Expression of Recombinant DNASE1, DNASE1L3, DNASE2, and DFFB Controlled by EGFR Promoter: Novel Strategy for Targeted Therapy of Cancer.Dexrazoxane abrogates acute doxorubicin toxicity in marmoset ovary Effect of ATM and HDAC Inhibition on Etoposide-Induced DNA Damage in Porcine Early Preimplantation Embryos.Increased DNA damage and repair deficiency in granulosa cells are associated with ovarian aging in rhesus monkey.Different fates of oocytes with DNA double-strand breaks in vitro and in vivo Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.Evaluation of ovarian and testicular tissue cryopreservation in children undergoing gonadotoxic therapies.Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy.Recent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes.An ovarian bioreactor for in vitro culture of the whole bovine ovary: a preliminary report Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?Multidrug-resistant transport activity protects oocytes from chemotherapeutic agents and changes during oocyte maturation Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death.Female fertility preservation: a clinical perspective.Current approach to fertility preservation by embryo cryopreservation Utility of GnRH-agonists for Fertility Preservation in Women With Operable Breast Cancer: Is It Protective?Telomeric impact of conventional chemotherapy.Sexual and fertility adverse effects associated with chemotherapy treatment in women.Chemotherapy-induced damage to ovary: mechanisms and clinical impact.Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue.History of ABVD alters the number of oocytes vitrified after in vitro maturation in fertility preservation candidates.Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility.p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3.Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas.mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy.Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.Multidrug resistance transporter-1 and breast cancer resistance protein protect against ovarian toxicity, and are essential in ovarian physiology.DNA double-strand breaks disrupted the spindle assembly in porcine oocytes.

P2860

Q26823947-6ED99E5D-38B8-4351-B040-8CAB6AF24683 Q28267696-EB8CF14D-3148-4D33-9B03-2F7309C3E711 Q28285540-15C45E50-B5C6-4184-BDCF-AE976FCACC3C Q33653485-D8F0149D-DCE6-4644-9F86-5C873B572AE1 Q33669250-46848696-E565-4F4A-87FE-5A16874EBBE2 Q33779879-B042844B-2E16-456C-94FB-21A4BB15F667 Q34005150-E3EF7FFA-E8B5-4F21-96AD-305DDEE03DC3 Q34307356-5C3A54E2-19CB-4660-9812-51DC3AB33AC1 Q34631202-5DE68455-E2ED-4A4D-9803-63CDB7C7D58C Q34764184-3C24C4F1-381F-401E-91BA-9F31F54648A7 Q34905992-4CB508F3-344D-4BE5-B43B-E0B0085BC806 Q35109273-3304251A-1F61-4205-8E41-DEA463549A3D Q35201332-DB5EF577-E1F4-4CAB-BF3D-260EE3918B50 Q35837921-3820986A-5821-4A58-B01E-DA0F21F58D28 Q35938140-BB0BFF3F-0CF1-4BE3-A5D4-99EA0FD5B933 Q36189081-0A9FA0C3-96D0-4C88-8742-5F09529704E5 Q36244267-F421EA08-C18F-4CBF-A15D-877AF54FD015 Q36557285-5AE7D56B-403F-4902-B86D-6B27A81CE4C0 Q36901831-F12F67E2-B291-4F3B-A39C-A8F36F12D75F Q36926098-BF74E56B-A3E0-4D46-A615-307291BADA09 Q37150839-3D6BBA78-3C93-4320-87D0-4B4136FB48BF Q37182982-DC8F52F2-B4C5-41D0-9934-972844CC995A Q37281939-5E28EF68-0B4A-4F80-8AD2-1B8BF36907A6 Q37387475-E5B9694E-7B25-4416-B71F-259D62C782BC Q37628888-29127E81-3809-4F6B-A92A-3B17E2B57942 Q37676012-099BD354-85E9-42F3-AE14-21B88BBE6B90 Q37679148-6F2B71FE-B394-45D9-8EAF-EB3BE57CD75F Q38155121-A258E281-8A5B-4890-A7EB-E9E7CA422BBB Q38208378-165A7A83-A498-451F-B6EF-928BB6F2CBAA Q38842887-F96A605A-1B2D-4A40-9FD8-1992176F41EE Q38867868-09ACD685-68D9-4A81-AAFD-FA30DE499973 Q38897383-69A7E414-42C6-4A37-A5F9-D37CDDECFC6F Q39026680-6486B383-7505-4D9D-A0BC-A47E8FEC7B72 Q39151472-5FB69B41-3596-4F38-B11E-F15C7987F41C Q39237016-D72B219D-EFC4-4049-BB2B-02C79308F5D8 Q39763050-D8DCE9BB-328E-4149-B78D-433DB28C59A4 Q41710033-42A4B958-DC0B-4A29-B8B9-6F476AB42164 Q46144166-02581400-EF37-45B7-91B5-A2AE5F8E5841 Q48528733-11594B4B-0D47-4AC9-B8BA-A0FE1D4CF750 Q48562637-BA1068A4-2682-43E6-9759-A15456EBF86A

P2860

Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise.

http://www.wikidata.org/entity/Q35254797

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Mechanisms of chemotherapy-ind ...... and microvascular compromise.

@ast

Mechanisms of chemotherapy-ind ...... and microvascular compromise.

@en

type

label

Mechanisms of chemotherapy-ind ...... and microvascular compromise.

@ast

Mechanisms of chemotherapy-ind ...... and microvascular compromise.

@en

prefLabel

Mechanisms of chemotherapy-ind ...... and microvascular compromise.

@ast

Mechanisms of chemotherapy-ind ...... and microvascular compromise.

@en

P1433

Q35254797-BEDAB632-0463-45FA-B8B5-5A23F903BD7B

P1476

Q35254797-0C46CD3C-8E95-44D9-BD56-0D358F1D5C7B

P2093

Q35254797-598CB0B0-07D3-4A87-907C-748C86172B91

Q35254797-D73A25A2-6820-4FA4-8040-802C22864E19

Q35254797-E7994681-A57A-468C-BC0C-589BCE8B6672

P2860

Q35254797-033575D5-DA9A-45B0-A6C1-CD163B704355

Q35254797-04606C50-F5CA-45FA-897D-CA5CAC47FBEE

Q35254797-1AE20E0F-C989-48E9-A9EA-DE2ECA3AA799

Q35254797-3318FE99-2883-477C-80F4-4ABC4033FF47

Q35254797-370915B0-BBD8-4BC0-ADE6-B2586E89BF43

Q35254797-48387621-4F3C-4E2E-97E0-FF263F622021

Q35254797-4A8384DF-3707-4AB6-854A-56425A88C34D

Q35254797-4FFD7E69-B5DE-4758-8126-3C408EAF51B9

Q35254797-511172D6-0ED1-4392-B102-50B61B34E9F7

Q35254797-5A0EE16F-FEEE-407B-A4D8-62A6F2C6C730

P304

Q35254797-8E5E60EA-9E5B-49C9-8A21-303A85DACFF6

P31

Q35254797-E9911659-F326-4781-A584-ECDA0C2CF405

P356

Q35254797-9C959687-9814-4841-B545-EBA12B5A1E98

P433

Q35254797-20FDF38D-7CAD-4D06-995C-39C9A6A12504

P478

Q35254797-362CCD52-4489-4EE3-9EF1-B9F25007234B

P50

Q35254797-612C7241-1281-45D8-80D9-36DD47CDE957

P577

Q35254797-91BA7ACA-C509-4E5C-94E5-5B44E64F8459

P698

Q35254797-FA48DEB1-A512-490D-B205-0C010B4228FB

P921

Q35254797-218D2B01-64B8-48A7-AC8D-A1E69A15EADA

P932

Q35254797-AF6E6462-9234-4710-AE6F-70A3D0668C36

P356

P1433

P1476

Mechanisms of chemotherapy-ind ...... and microvascular compromise.

@en

P2093

Elke Heytens

http://www.w3.org/2001/XMLSchema#string

Kutluk Oktay

http://www.w3.org/2001/XMLSchema#string

Reza Soleimani

http://www.w3.org/2001/XMLSchema#string

P2860

Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks

Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants

Interaction between ATM protein and c-Abl in response to DNA damage

Chemotherapy-induced late transgenerational effects in mice

Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system

Defective neurogenesis resulting from DNA ligase IV deficiency requires Atm

p63 protects the female germ line during meiotic arrest

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM

Pregnancy outcome of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

New biomarkers probing depth of cell senescence assessed by laser scanning cytometry.

P304

782-793

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/AGING.100363

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Zbyszek Darzynkiewicz

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21869459

http://www.w3.org/2001/XMLSchema#string

P921

P932

3184979

http://www.w3.org/2001/XMLSchema#string